These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 19016717

  • 1. Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells.
    Fei F, Yu Y, Schmitt A, Rojewski MT, Chen B, Götz M, Döhner H, Bunjes D, Schmitt M.
    Br J Haematol; 2009 Jan; 144(2):195-205. PubMed ID: 19016717
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW, Zhou RB, Yao YM, Zhu XM, Yin YM, Zhao GJ, Dong N, Sheng ZY.
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [Abstract] [Full Text] [Related]

  • 3. The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro.
    Blake S, Hughes TP, Mayrhofer G, Lyons AB.
    Clin Immunol; 2008 Jun; 127(3):330-9. PubMed ID: 18395492
    [Abstract] [Full Text] [Related]

  • 4. Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens.
    Fei F, Yu Y, Schmitt A, Rojewski MT, Chen B, Greiner J, Götz M, Guillaume P, Döhner H, Bunjes D, Schmitt M.
    Exp Hematol; 2008 Oct; 36(10):1297-308. PubMed ID: 18619726
    [Abstract] [Full Text] [Related]

  • 5. Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo.
    Fraser CK, Blake SJ, Diener KR, Lyons AB, Brown MP, Hughes TP, Hayball JD.
    Exp Hematol; 2009 Feb; 37(2):256-65. PubMed ID: 19056158
    [Abstract] [Full Text] [Related]

  • 6. Combining dasatinib with dexamethasone long-term leads to maintenance of antiviral and antileukemia specific cytotoxic T cell responses in vitro.
    Nerreter T, Distler E, Köchel C, Einsele H, Herr W, Seggewiss-Bernhardt R.
    Exp Hematol; 2013 Jul; 41(7):604-614.e4. PubMed ID: 23466625
    [Abstract] [Full Text] [Related]

  • 7. Regulatory T cells in chronic hepatitis B patients affect the immunopathogenesis of hepatocellular carcinoma by suppressing the anti-tumour immune responses.
    Zhang HH, Mei MH, Fei R, Liu F, Wang JH, Liao WJ, Qin LL, Wei L, Chen HS.
    J Viral Hepat; 2010 Mar; 17 Suppl 1():34-43. PubMed ID: 20586932
    [Abstract] [Full Text] [Related]

  • 8. Effects of nilotinib on regulatory T cells: the dose matters.
    Fei F, Yu Y, Schmitt A, Rojewski MT, Chen B, Greiner J, Götz M, Bunjes D, Schmitt M.
    Mol Cancer; 2010 Jan 29; 9():22. PubMed ID: 20113470
    [Abstract] [Full Text] [Related]

  • 9. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J, Jiang S, Tanriver Y, Leung E, Lombardi G, Lechler RI.
    Int Immunopharmacol; 2006 Dec 20; 6(13-14):1883-8. PubMed ID: 17161341
    [Abstract] [Full Text] [Related]

  • 10. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro.
    Yates J, Rovis F, Mitchell P, Afzali B, Tsang J, Garin M, Lechler RI, Lombardi G, Garden OA.
    Int Immunol; 2007 Jun 20; 19(6):785-99. PubMed ID: 17545278
    [Abstract] [Full Text] [Related]

  • 11. Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner.
    Chen J, Schmitt A, Giannopoulos K, Chen B, Rojewski M, Döhner H, Bunjes D, Schmitt M.
    Int J Oncol; 2007 Nov 20; 31(5):1133-9. PubMed ID: 17912440
    [Abstract] [Full Text] [Related]

  • 12. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS, Krishnadas DK, Agrawal B.
    Int Immunol; 2007 Mar 20; 19(3):227-37. PubMed ID: 17289657
    [Abstract] [Full Text] [Related]

  • 13. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
    Giorgini A, Noble A.
    J Leukoc Biol; 2007 Nov 20; 82(5):1053-61. PubMed ID: 17684039
    [Abstract] [Full Text] [Related]

  • 14. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K, Borysowski J, Wierzbicki P, Wyzgal J, Klosowska D, Bialoszewska A, Paczek L, Górski A, Korczak-Kowalska G.
    Nephrol Dial Transplant; 2010 Mar 20; 25(3):710-7. PubMed ID: 19903662
    [Abstract] [Full Text] [Related]

  • 15. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY, Yao YM, Zhang L, Dong N, Zhang QH, Yu Y, Sheng ZY.
    Mol Immunol; 2011 Oct 20; 49(1-2):219-26. PubMed ID: 21963221
    [Abstract] [Full Text] [Related]

  • 16. The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats.
    Huang LF, Yao YM, Zhang LT, Dong N, Yu Y, Sheng ZY.
    Shock; 2009 Mar 20; 31(3):322-9. PubMed ID: 18665051
    [Abstract] [Full Text] [Related]

  • 17. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
    Bianchini R, Bistoni O, Alunno A, Petrillo MG, Ronchetti S, Sportoletti P, Bocci EB, Nocentini G, Gerli R, Riccardi C.
    Eur J Immunol; 2011 Aug 20; 41(8):2269-78. PubMed ID: 21557210
    [Abstract] [Full Text] [Related]

  • 18. CD4+CD25+ Treg derived from hepatocellular carcinoma mice inhibits tumor immunity.
    Chen X, Du Y, Huang Z.
    Immunol Lett; 2012 Aug 20; 148(1):83-9. PubMed ID: 23000301
    [Abstract] [Full Text] [Related]

  • 19. Plasmodium vivax: induction of CD4+CD25+FoxP3+ regulatory T cells during infection are directly associated with level of circulating parasites.
    Bueno LL, Morais CG, Araújo FF, Gomes JA, Corrêa-Oliveira R, Soares IS, Lacerda MV, Fujiwara RT, Braga EM.
    PLoS One; 2010 Mar 10; 5(3):e9623. PubMed ID: 20224778
    [Abstract] [Full Text] [Related]

  • 20. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF, Gao J, Zhang D, Wang ZH, Zhu JY.
    Chin Med J (Engl); 2010 Apr 05; 123(7):942-8. PubMed ID: 20497692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.